Authorized Disclosures. Subject to this Section 8.3, the recipient Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 15 contracts
Samples: Eli Lilly and Company, Collaboration and License Agreement (AbCellera Biologics Inc.), Collaboration and License Agreement (AbCellera Biologics Inc.)
Authorized Disclosures. Subject to this Section 8.3Notwithstanding the obligations set forth in Sections 11.1 and 11.5, the recipient a Party may disclose the other Party’s Confidential Information belonging (including this Agreement and the terms herein) to the other Party to the extent permitted as followsextent:
Appears in 13 contracts
Samples: License and Collaboration Agreement (Pandion Therapeutics Holdco LLC), License and Collaboration Agreement (Pandion Therapeutics Holdco LLC), License and Collaboration Agreement (Pandion Therapeutics Holdco LLC)
Authorized Disclosures. Subject to this Section 8.310.3, the recipient Receiving Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 5 contracts
Samples: License and Collaboration Agreement (Zymeworks Inc.), License and Collaboration Agreement (Zymeworks Inc.), License and Collaboration Agreement (Jazz Pharmaceuticals PLC)
Authorized Disclosures. Subject to this Section 8.37.3, the recipient Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 4 contracts
Samples: License Agreement, License Agreement (Zymeworks Inc.), And License Agreement (Zymeworks Inc.)
Authorized Disclosures. Subject to this Section 8.39.4, the recipient Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 2 contracts
Samples: Research and License Agreement (Zymeworks Inc.), Research and License Agreement (Zymeworks Inc.)
Authorized Disclosures. Subject to this Section 8.3, the recipient Party may disclose Confidential Information (including the Agreement) belonging to the other Party to the extent permitted as followsParty:
Appears in 2 contracts
Samples: Patent Cross License Agreement (Alnylam Pharmaceuticals, Inc.), Patent Cross License Agreement (Dicerna Pharmaceuticals Inc)
Authorized Disclosures. Subject to this Section 8.39.3, the recipient Receiving Party may disclose the Disclosing Party’s Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 2 contracts
Samples: License Agreement (Erasca, Inc.), License Agreement (Erasca, Inc.)
Authorized Disclosures. Subject to this Section 8.311.3, the recipient Party may disclose Confidential Information (including the Agreement) belonging to the other Party to the extent permitted as follows:
Appears in 1 contract
Samples: Collaboration and License Agreement (Dicerna Pharmaceuticals Inc)
Authorized Disclosures. Subject to this Section 8.310.3 and Section 7 of Exhibit 2.8, the recipient Receiving Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 1 contract
Samples: Collaboration Agreement (Assembly Biosciences, Inc.)
Authorized Disclosures. Subject to this Section 8.3, the recipient Party may disclose Confidential Information (including the Agreement) belonging to the other Party Party: Certain information in this Exhibit marked as [***] has been excluded pursuant to the extent permitted as follows:Regulation S-K, Item 601(b)(10). Such excluded information is not material and would be competitively harmful if publicly disclosed.
Appears in 1 contract
Samples: Collaboration and License Agreement (Centrexion Therapeutics Corp)
Authorized Disclosures. Subject to this Section 8.311.3, the recipient Party may disclose Confidential Information (including the Agreement) belonging to the other Party to the extent permitted as followsParty:
Appears in 1 contract
Samples: Collaboration and License Agreement (Dicerna Pharmaceuticals Inc)
Authorized Disclosures. Subject to this Section 8.39.3, the recipient Party may disclose Confidential Information (including the Agreement) belonging to the other Party to the extent permitted as followsParty:
Appears in 1 contract
Samples: Collaboration and License Agreement (Dicerna Pharmaceuticals Inc)
Authorized Disclosures. Subject to this Section 8.37.3, the recipient Receiving Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 1 contract
Authorized Disclosures. Subject to this Section 8.315(c), the recipient receiving Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 1 contract
Samples: License Agreement (Biolargo, Inc.)
Authorized Disclosures. Subject to this Section 8.39.3, the recipient Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 1 contract
Samples: Research Collaboration and License Agreement (BCTG Acquisition Corp.)
Authorized Disclosures. Subject to this Section 8.311(c), the recipient receiving Party may disclose Confidential Information belonging to the other Party to the extent permitted as follows:
Appears in 1 contract
Samples: License Agreement (Biolargo, Inc.)
